SYNCOM FORMULATIONS (INDIA)
|
The Current P/S Ratio of SYNCOM FORMULATIONS (INDIA) is 4.04.
| Share Price | ₹21.4 | Sep 02,2026 |
| Market Cap | ₹2,010.7 Cr | |
| Sales-TTM | ₹497.8 Cr | TTM-Consolidated Results |
| Price/Sales | 4.04x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SYNCOM FORMULATIONS (INDIA)
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹2,010.7 Cr] as on Sep 02,2026
(/) Sales [ ₹497.8 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.04x ]
Thus, for SYNCOM FORMULATIONS (INDIA) , the investors are currently willing to pay '4.04 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SYNCOM FORMULATIONS (INDIA) !
The chart below summarizes the trend in P/S Ratio of SYNCOM FORMULATIONS (INDIA) over the last five years.
Historical PS (Price/Sales) ratio chart of SYNCOM FORMULATIONS (INDIA)
PS Ratio Performance Analysis for SYNCOM FORMULATIONS (INDIA)
- SYNCOM FORMULATIONS (INDIA) 's p/e ratio for fiscal years ending Mar2025 to Mar2017 averaged 2.96x.
- SYNCOM FORMULATIONS (INDIA) 's operated at median p/e ratio of 3.33x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SYNCOM FORMULATIONS (INDIA) 's p/e ratio peaked in Mar2022 at 4.17x.
- SYNCOM FORMULATIONS (INDIA) 's p/e ratio hit its five-year low in Mar2017 of 0.83x.
How does SYNCOM FORMULATIONS (INDIA) 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SYNCOM FORMULATIONS (INDIA) | 497.8 | 4.04 | 2,010.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.74 | 463,791.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 21.82 | 245,081.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 12.11 | 190,351.0 |
| CIPLA LTD | 28,324.4 | 4.03 | 114,163.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.92 | 96,906.3 |
| MANKIND PHARMA LTD | 14,737.9 | 6.67 | 98,304.7 |
| LUPIN LTD | 29,966.6 | 3.28 | 98,431.0 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.02 | 114,833.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.73 | 95,299.8 |
| LAURUS LABS LTD | 7,269.6 | 13.85 | 100,660.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SYNCOM FORMULATIONS (INDIA) 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.73x |
| Max industry PS | 21.82x |
| Median industry PS | 4.04x |
| Average industry PS | 7.56x |
You may also like the below Video Courses